These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 10600280

  • 1. Effects of nitric oxide synthesis inhibition on the Na,K-ATPase activity in the kidney.
    Kang DG, Kim JW, Lee J.
    Pharmacol Res; 2000 Jan; 41(1):123-7. PubMed ID: 10600280
    [Abstract] [Full Text] [Related]

  • 2. EFFECTS OF NITRIC OXIDE SYNTHESIS INHIBITION ON THE Na,K-ATPase ACTIVITY IN THE KIDNEY.
    Kang DG, Kim JW, Lee J.
    Pharmacol Res; 2000 Jan; 41(1):121-125. PubMed ID: 10712837
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of maturation on renal Na+/K+-atpase and its susceptibility to nitric oxide-deficient hypertension in rats.
    Javorková V, Vlkovicova J, Kunes J, Pechanova O, Zicha J, Vrbjar N.
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):617-23. PubMed ID: 17581218
    [Abstract] [Full Text] [Related]

  • 5. Changes of sodium and ATP affinities of the renal Na,K-ATPase during and after nitric oxide-deficient hypertension.
    Vrbjar N, Javorková V, Pechánová O.
    Physiol Res; 2002 Jul; 51(5):475-81. PubMed ID: 12470200
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Nitric oxide synthase inhibition by L-NAME prevents the decrease of Na+,K+-ATPase activity in midbrain of rats subjected to arginine administration.
    Wyse AT, Bavaresco CS, Bandinelli C, Streck EL, Franzon R, Dutra-Filho CS, Wajner M.
    Neurochem Res; 2001 May; 26(5):515-20. PubMed ID: 11513478
    [Abstract] [Full Text] [Related]

  • 8. Chronic nitric oxide synthase inhibition exacerbates renal dysfunction in cirrhotic rats.
    Graebe M, Brond L, Christensen S, Nielsen S, Olsen NV, Jonassen TE.
    Am J Physiol Renal Physiol; 2004 Feb; 286(2):F288-97. PubMed ID: 14583432
    [Abstract] [Full Text] [Related]

  • 9. Cyclooxygenase pathway is involved in the vascular reactivity and inhibition of the Na+, K+-ATPase activity in the tail artery from L-NAME-treated rats.
    dos Santos L, Xavier FE, Vassallo DV, Rossoni LV.
    Life Sci; 2003 Dec 19; 74(5):613-27. PubMed ID: 14623032
    [Abstract] [Full Text] [Related]

  • 10. Relationship between PPARalpha activation and NO on proximal tubular Na+ transport in the rat.
    Newaz MA, Ranganna K, Oyekan AO.
    BMC Pharmacol; 2004 Feb 06; 4():1. PubMed ID: 15018640
    [Abstract] [Full Text] [Related]

  • 11. Short-term NO synthase inhibition and the Na+-binding properties of cardiac Na,K-ATPase.
    Vrbjar N, Strnisková M, Pechánová O, Gerová M.
    Physiol Res; 2000 Feb 06; 49(1):65-70. PubMed ID: 10805406
    [Abstract] [Full Text] [Related]

  • 12. Defective nitric oxide production impairs angiotensin II-induced Na-K-ATPase regulation in spontaneously hypertensive rats.
    Javkhedkar AA, Lokhandwala MF, Banday AA.
    Am J Physiol Renal Physiol; 2012 Jan 01; 302(1):F47-51. PubMed ID: 21900450
    [Abstract] [Full Text] [Related]

  • 13. Chronic nitric oxide blockade modulates renal Na-K-2Cl cotransporters.
    Wangensteen R, Rodríguez-Gomez I, Moreno JM, Vargas F, Alvarez-Guerra M.
    J Hypertens; 2006 Dec 01; 24(12):2451-8. PubMed ID: 17082729
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Carbachol and nitric oxide inhibition of Na,K-ATPase activity in bovine ciliary processes.
    Ellis DZ, Nathanson JA, Rabe J, Sweadner KJ.
    Invest Ophthalmol Vis Sci; 2001 Oct 01; 42(11):2625-31. PubMed ID: 11581209
    [Abstract] [Full Text] [Related]

  • 16. Nitric oxide regulates cardiac intracellular Na⁺ and Ca²⁺ by modulating Na/K ATPase via PKCε and phospholemman-dependent mechanism.
    Pavlovic D, Hall AR, Kennington EJ, Aughton K, Boguslavskyi A, Fuller W, Despa S, Bers DM, Shattock MJ.
    J Mol Cell Cardiol; 2013 Aug 01; 61():164-71. PubMed ID: 23612119
    [Abstract] [Full Text] [Related]

  • 17. Spermidine decreases Na⁺,K⁺-ATPase activity through NMDA receptor and protein kinase G activation in the hippocampus of rats.
    Carvalho FB, Mello CF, Marisco PC, Tonello R, Girardi BA, Ferreira J, Oliveira MS, Rubin MA.
    Eur J Pharmacol; 2012 Jun 05; 684(1-3):79-86. PubMed ID: 22497998
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Arginine administration inhibits hippocampal Na(+),K(+)-ATPase activity and impairs retention of an inhibitory avoidance task in rats.
    dos Reis EA, de Oliveira LS, Lamers ML, Netto CA, Wyse AT.
    Brain Res; 2002 Oct 04; 951(2):151-7. PubMed ID: 12270492
    [Abstract] [Full Text] [Related]

  • 20. NO donors inhibit Na,K-ATPase activity by a protein kinase G-dependent mechanism in the nonpigmented ciliary epithelium of the porcine eye.
    Shahidullah M, Delamere NA.
    Br J Pharmacol; 2006 Jul 04; 148(6):871-80. PubMed ID: 16770322
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.